About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA recently submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed rule which would extend coverage of anti-obesity medicines (AOMs) in Medicare Part D and state Medicaid plans. Currently, AOMs are excluded from Medicare Part D coverage and optional in state Medicaid programs, when used specifically for the treatment of obesity, because they’re labeled as “agents used for weight loss.”
PhRMA Comments to CMS on Contract Year 2026 Medicare Advantage and Part D Proposed Rule preview
Report
Medicare
PhRMA Comments to CMS on Contract Year 2026 Medicare Advantage and Part D Proposed Rule
PhRMA Comments to CMS on Contract Year 2026 Medicare Advantage and Part D Proposed Rule preview